ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
Dow Jones
38,589.16
-0.15%
Brent Oil
82.275
0.00%
Bitcoin
66,066.95
-0.19%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Progen Industries (PGLAF)

  7. Progen Industries (PGLAF) News

PGLAF

Progen (PGLAF)

Progen Industries
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PGLAF
DateTimeSourceHeadlineSymbolCompany
05/16/20066:53AMPR Newswire (US)Progen Prepares for Accelerated Clinical Development of PI-88 Following FDA MeetingNASDAQ:PGLAFProgen Industries
08/09/20057:00AMPR Newswire (US)Progen Expand PI-88 Clinical Development to Prostate CancerNASDAQ:PGLAF
06/28/20051:28AMPR Newswire (US)Progen Engages Burrill to Advance PI-88 Partnering DiscussionsNASDAQ:PGLAF
05/17/200512:14AMPR Newswire (US)Results of PI-88 Phase II Clinical Trial in Melanoma Presented at ASCONASDAQ:PGLAFProgen Industries
08/27/200412:53AMPR Newswire (US)Progen Reports Solid Financial PerformanceNASDAQ:PGLAFProgen Industries
07/13/200411:36PMPR Newswire (US)PI-88 Phase II Clinical Trial Targeting Liver Cancer LaunchedNASDAQ:PGLAFProgen Industries
05/03/200410:49PMPR Newswire (US)U.S. FDA Grants Orphan Drug Status to PI-88 for MelanomaNASDAQ:PGLAF
02/27/20046:00AMPR Newswire (US)Half Year Report - Progen on Track to Meet MilestonesNASDAQ:PGLAF
02/10/200411:48PMPR Newswire (US)Progen Commences Third PI-88 Phase II TrialNASDAQ:PGLAFProgen Industries
11/18/200310:20PMPR Newswire (US)Bonus Issue of Options - Record Date November 28 2003NASDAQ:PGLAFProgen Industries
11/10/20038:58PMPR Newswire (US)Progen Sharpens Cancer Focus Through DivestmentNASDAQ:PGLAF
10/31/20031:43AMPR Newswire (US)Progen Industries Limited New Placement Terms AnnouncedNASDAQ:PGLAFProgen Industries
10/31/20031:30AMPR Newswire (US)Progen Industries Limited Annual General MeetingNASDAQ:PGLAF
10/28/20038:42PMPR Newswire (US)Progen Granted Anti-Angiogenesis Antibody PatentNASDAQ:PGLAFProgen Industries
 Showing the most relevant articles for your search:NASDAQ:PGLAF

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
CLNV
Clean Vision (QB)
USOTC
CNNA
Cann American (CE)
USOTC
HHSE
Hannover House (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
CIVX
CTR Investments and Cons... (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
VXIT
Virexit Technologies (PK)
USOTC
BLLB
Bell Buckle (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved